☆ 4.7 Article

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

CLINICAL CANCER RESEARCH (2015)

Get Full Text
Add to Collection

Journal

CLINICAL CANCER RESEARCH
Volume 21, Issue 18, Pages 4062-4072

Publisher

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-15-0428

Keywords

-

Categories

Oncology

Funding

  1. NIH [P30 CA33572, R01 CA103959, R01 C75155769, R21 NS081594, R21 CA189223]
  2. California Institute for Regenerative Medicine (CIRM) [TR3-05641]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.